Gilead Sciences
Manufacturing · California, United States · 10K+ Employees
View Company Info for Free
Overview
Headquarters
333 Lakeside Dr, Foster City, California...Phone Number
(650) 574-3000Website
www.gilead.comRevenue
$30.5 BillionStock Symbol
GILDIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
3
3
3
2
1
About Gilead Sciences
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, InRead more
Gilead Sciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Gilead Sciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Gilead Sciences is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Gilead Sciences
Check if Gilead Sciences has recently received funding, and reach out quickly before it becomes old news!
Gilead Sciences, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Gilead Sciences has new funding data
Earning: See what the market has to say on Gilead Sciences recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Gilead Sciences had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Gilead Sciences launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Gilead Sciences
Compare insights from companies similar to Gilead Sciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$48.5B
10K+
Public
$4B
1887
Joshua SugrimManager, Chief Technology Officer MSAT Process Validation - CAR T Cell Therapy
Products Owned by Gilead Sciences
Gild
Company Profile Activity
Activity Insights
Gilead Sciences is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Gilead Sciences is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Gilead Sciences.
Gilead Sciences financials insights
Gather financial insights about Gilead Sciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
1992
Stock Offering
$86.3M
2024
Other Financing Round
$210M
Gilead Sciences Tech Stack
A closer look at the technologies used by Gilead Sciences
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Open Position
Gilead Sciences News & Media
Gilead Sciences Has Quietly Become One of the Most Underrated Turnaround Stories in Healthcare. Here's Why Wall Street Is Excited.
The company's HIV franchise is stronger than ever, and it's adding a stable of oncology drugs.Gilead Sciences Q2 Earnings Call Highlights
Gilead Sciences (NASDAQ:GILD) reported second-quarter 2026 base business sales growth of 10% year over year to $7.6 billion, supported by HIV treatments and prevention products, Trodelvy in oncology and Livdelzi in liver disease. The company raised its full-year base business sales outlook and increGilead Sciences (GILD) Q2 Earnings Report Preview: What To Look For
Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) will be reporting earnings this Tuesday after market hours. Here’s what to expect.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Gilead Sciences
Sign Up For FreeTo access detailed company insights
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Vek... Read More
